Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression

Serkan Zincir,1 Pelin Öztürk,2 Ali Emrah Bilgen,3 Filiz İzci,4 Cihad Yükselir5 1Department of Psychiatry, Gölcük Military Hospital, Kocaeli, 2Psychiatry Clinic, Erenkoy Training and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, 3...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zincir S, Öztürk P, Bilgen AE, İzci F, Yükselir C
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
ECT
Acceso en línea:https://doaj.org/article/db22b26cdbeb40329ffcb90bfda7de6c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:db22b26cdbeb40329ffcb90bfda7de6c
record_format dspace
spelling oai:doaj.org-article:db22b26cdbeb40329ffcb90bfda7de6c2021-12-02T11:02:20ZLevels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression1178-2021https://doaj.org/article/db22b26cdbeb40329ffcb90bfda7de6c2016-06-01T00:00:00Zhttps://www.dovepress.com/levels-of-serum-immunomodulators-and-alterations-with-electroconvulsiv-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Serkan Zincir,1 Pelin Öztürk,2 Ali Emrah Bilgen,3 Filiz İzci,4 Cihad Yükselir5 1Department of Psychiatry, Gölcük Military Hospital, Kocaeli, 2Psychiatry Clinic, Erenkoy Training and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, 3Department of Psychiatry, Etimesgut Military Hospital, Ankara, 4Department of Psychiatry, Istanbul Bilim University, Istanbul, 5Department of Psychiatry, Gulhane Military Medical Faculty, Ankara, Turkey Abstract: Studies in recent years have indicated that neuroimmunological events and immune activation may have a place in the etiology of depression. It has been suggested from data that there is a causal relationship between activation of the immune system and excessive release of proinflammatory cytokines, such as interleukin 1 (IL-1), IL-6, and tumor necrosis factor-alpha (TNF-alpha), and the etiology of depression. Although the mechanism of action of electroconvulsive therapy (ECT) is unclear, there is evidence that it can reduce cytokines and immune system changes. In our study, we aimed to determine how levels of serum immunomodulators were affected by ECT in major depression patients. This study was conducted on 50 patients with treatment-resistant major depression. The data of the patients were compared with 30 healthy individuals with similar demographic characteristics. A clinical response occurred in the patients and at the end of therapy, IL-1, IL-6, TNF-alpha, IL-10, IL-4, and interferon-gamma levels were measured. The disease severity was assessed with the 17-item Hamilton Depression Rating Scale. Data analysis was performed using SPSS Version 15. Significant differences were determined between the patients with major depression and control group with respect to basal serum IL-1, IL-6, TNF-alpha, IL-10, IL-4, and interferon-gamma levels. ECT treatment was shown to reduce these differences. ECT may cause significant changes in the activity of the immune system. The consideration of the relationship between the immune endocrine neurotransmitter systems could contribute to new theories regarding the mechanism of antidepressant treatment and biology of depression. Keywords: the pathophysiology of depression, the immune system, cytokinesZincir SÖztürk PBilgen AEİzci FYükselir CDove Medical Pressarticlemajor depressionECTthe immune systemcytokinesNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2016, Iss Issue 1, Pp 1389-1396 (2016)
institution DOAJ
collection DOAJ
language EN
topic major depression
ECT
the immune system
cytokines
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle major depression
ECT
the immune system
cytokines
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Zincir S
Öztürk P
Bilgen AE
İzci F
Yükselir C
Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression
description Serkan Zincir,1 Pelin Öztürk,2 Ali Emrah Bilgen,3 Filiz İzci,4 Cihad Yükselir5 1Department of Psychiatry, Gölcük Military Hospital, Kocaeli, 2Psychiatry Clinic, Erenkoy Training and Research Hospital for Psychiatric and Neurological Diseases, Istanbul, 3Department of Psychiatry, Etimesgut Military Hospital, Ankara, 4Department of Psychiatry, Istanbul Bilim University, Istanbul, 5Department of Psychiatry, Gulhane Military Medical Faculty, Ankara, Turkey Abstract: Studies in recent years have indicated that neuroimmunological events and immune activation may have a place in the etiology of depression. It has been suggested from data that there is a causal relationship between activation of the immune system and excessive release of proinflammatory cytokines, such as interleukin 1 (IL-1), IL-6, and tumor necrosis factor-alpha (TNF-alpha), and the etiology of depression. Although the mechanism of action of electroconvulsive therapy (ECT) is unclear, there is evidence that it can reduce cytokines and immune system changes. In our study, we aimed to determine how levels of serum immunomodulators were affected by ECT in major depression patients. This study was conducted on 50 patients with treatment-resistant major depression. The data of the patients were compared with 30 healthy individuals with similar demographic characteristics. A clinical response occurred in the patients and at the end of therapy, IL-1, IL-6, TNF-alpha, IL-10, IL-4, and interferon-gamma levels were measured. The disease severity was assessed with the 17-item Hamilton Depression Rating Scale. Data analysis was performed using SPSS Version 15. Significant differences were determined between the patients with major depression and control group with respect to basal serum IL-1, IL-6, TNF-alpha, IL-10, IL-4, and interferon-gamma levels. ECT treatment was shown to reduce these differences. ECT may cause significant changes in the activity of the immune system. The consideration of the relationship between the immune endocrine neurotransmitter systems could contribute to new theories regarding the mechanism of antidepressant treatment and biology of depression. Keywords: the pathophysiology of depression, the immune system, cytokines
format article
author Zincir S
Öztürk P
Bilgen AE
İzci F
Yükselir C
author_facet Zincir S
Öztürk P
Bilgen AE
İzci F
Yükselir C
author_sort Zincir S
title Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression
title_short Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression
title_full Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression
title_fullStr Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression
title_full_unstemmed Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression
title_sort levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/db22b26cdbeb40329ffcb90bfda7de6c
work_keys_str_mv AT zincirs levelsofserumimmunomodulatorsandalterationswithelectroconvulsivetherapyintreatmentresistantmajordepression
AT ozturkp levelsofserumimmunomodulatorsandalterationswithelectroconvulsivetherapyintreatmentresistantmajordepression
AT bilgenae levelsofserumimmunomodulatorsandalterationswithelectroconvulsivetherapyintreatmentresistantmajordepression
AT izcif levelsofserumimmunomodulatorsandalterationswithelectroconvulsivetherapyintreatmentresistantmajordepression
AT yukselirc levelsofserumimmunomodulatorsandalterationswithelectroconvulsivetherapyintreatmentresistantmajordepression
_version_ 1718396321897906176